Global Short Bowel Syndrome Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Short Bowel Syndrome Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Short Bowel Syndrome Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Short Bowel Syndrome Drugs by Country/Region, 2017, 2022 & 2028

2.2 Short Bowel Syndrome Drugs Segment by Type

2.2.1 Oral Short Bowel Syndrome Drugs

2.2.2 Tablet Short Bowel Syndrome Drugs

2.3 Short Bowel Syndrome Drugs Sales by Type

2.3.1 Global Short Bowel Syndrome Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Short Bowel Syndrome Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Short Bowel Syndrome Drugs Sale Price by Type (2017-2022)

2.4 Short Bowel Syndrome Drugs Segment by Sale Channel

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.5 Short Bowel Syndrome Drugs Sales by Sale Channel

2.5.1 Global Short Bowel Syndrome Drugs Sale Market Share by Sale Channel (2017-2022)

2.5.2 Global Short Bowel Syndrome Drugs Revenue and Market Share by Sale Channel (2017-2022)

2.5.3 Global Short Bowel Syndrome Drugs Sale Price by Sale Channel (2017-2022)

3 Global Short Bowel Syndrome Drugs by Company

3.1 Global Short Bowel Syndrome Drugs Breakdown Data by Company

3.1.1 Global Short Bowel Syndrome Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Short Bowel Syndrome Drugs Sales Market Share by Company (2020-2022)

3.2 Global Short Bowel Syndrome Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Short Bowel Syndrome Drugs Revenue by Company (2020-2022)

3.2.2 Global Short Bowel Syndrome Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Short Bowel Syndrome Drugs Sale Price by Company

3.4 Key Manufacturers Short Bowel Syndrome Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Short Bowel Syndrome Drugs Product Location Distribution

3.4.2 Players Short Bowel Syndrome Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Short Bowel Syndrome Drugs by Geographic Region

4.1 World Historic Short Bowel Syndrome Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Short Bowel Syndrome Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Short Bowel Syndrome Drugs Annual Revenue by Geographic Region

4.2 World Historic Short Bowel Syndrome Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Short Bowel Syndrome Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Short Bowel Syndrome Drugs Annual Revenue by Country/Region

4.3 Americas Short Bowel Syndrome Drugs Sales Growth

4.4 APAC Short Bowel Syndrome Drugs Sales Growth

4.5 Europe Short Bowel Syndrome Drugs Sales Growth

4.6 Middle East & Africa Short Bowel Syndrome Drugs Sales Growth

5 Americas

5.1 Americas Short Bowel Syndrome Drugs Sales by Country

5.1.1 Americas Short Bowel Syndrome Drugs Sales by Country (2017-2022)

5.1.2 Americas Short Bowel Syndrome Drugs Revenue by Country (2017-2022)

5.2 Americas Short Bowel Syndrome Drugs Sales by Type

5.3 Americas Short Bowel Syndrome Drugs Sales by Sale Channel

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Short Bowel Syndrome Drugs Sales by Region

6.1.1 APAC Short Bowel Syndrome Drugs Sales by Region (2017-2022)

6.1.2 APAC Short Bowel Syndrome Drugs Revenue by Region (2017-2022)

6.2 APAC Short Bowel Syndrome Drugs Sales by Type

6.3 APAC Short Bowel Syndrome Drugs Sales by Sale Channel

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Short Bowel Syndrome Drugs by Country

7.1.1 Europe Short Bowel Syndrome Drugs Sales by Country (2017-2022)

7.1.2 Europe Short Bowel Syndrome Drugs Revenue by Country (2017-2022)

7.2 Europe Short Bowel Syndrome Drugs Sales by Type

7.3 Europe Short Bowel Syndrome Drugs Sales by Sale Channel

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Short Bowel Syndrome Drugs by Country

8.1.1 Middle East & Africa Short Bowel Syndrome Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Short Bowel Syndrome Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Short Bowel Syndrome Drugs Sales by Type

8.3 Middle East & Africa Short Bowel Syndrome Drugs Sales by Sale Channel

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Short Bowel Syndrome Drugs

10.3 Manufacturing Process Analysis of Short Bowel Syndrome Drugs

10.4 Industry Chain Structure of Short Bowel Syndrome Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Short Bowel Syndrome Drugs Distributors

11.3 Short Bowel Syndrome Drugs Customer

12 World Forecast Review for Short Bowel Syndrome Drugs by Geographic Region

12.1 Global Short Bowel Syndrome Drugs Market Size Forecast by Region

12.1.1 Global Short Bowel Syndrome Drugs Forecast by Region (2023-2028)

12.1.2 Global Short Bowel Syndrome Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Short Bowel Syndrome Drugs Forecast by Type

12.7 Global Short Bowel Syndrome Drugs Forecast by Sale Channel

13 Key Players Analysis

13.1 Emmaus Medical

13.1.1 Emmaus Medical Company Information

13.1.2 Emmaus Medical Short Bowel Syndrome Drugs Product Offered

13.1.3 Emmaus Medical Short Bowel Syndrome Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Emmaus Medical Main Business Overview

13.1.5 Emmaus Medical Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Short Bowel Syndrome Drugs Product Offered

13.2.3 Merck Short Bowel Syndrome Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 Takeda

13.3.1 Takeda Company Information

13.3.2 Takeda Short Bowel Syndrome Drugs Product Offered

13.3.3 Takeda Short Bowel Syndrome Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Takeda Main Business Overview

13.3.5 Takeda Latest Developments

13.4 Ardelyx

13.4.1 Ardelyx Company Information

13.4.2 Ardelyx Short Bowel Syndrome Drugs Product Offered

13.4.3 Ardelyx Short Bowel Syndrome Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Ardelyx Main Business Overview

13.4.5 Ardelyx Latest Developments

13.5 Naia Pharmaceuticals

13.5.1 Naia Pharmaceuticals Company Information

13.5.2 Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Offered

13.5.3 Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Naia Pharmaceuticals Main Business Overview

13.5.5 Naia Pharmaceuticals Latest Developments

13.6 Nutrinia

13.6.1 Nutrinia Company Information

13.6.2 Nutrinia Short Bowel Syndrome Drugs Product Offered

13.6.3 Nutrinia Short Bowel Syndrome Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Nutrinia Main Business Overview

13.6.5 Nutrinia Latest Developments

13.7 OxThera

13.7.1 OxThera Company Information

13.7.2 OxThera Short Bowel Syndrome Drugs Product Offered

13.7.3 OxThera Short Bowel Syndrome Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 OxThera Main Business Overview

13.7.5 OxThera Latest Developments

13.8 GLyPharma Therapeutic

13.8.1 GLyPharma Therapeutic Company Information

13.8.2 GLyPharma Therapeutic Short Bowel Syndrome Drugs Product Offered

13.8.3 GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 GLyPharma Therapeutic Main Business Overview

13.8.5 GLyPharma Therapeutic Latest Developments

13.9 Sancilio Pharmaceuticals

13.9.1 Sancilio Pharmaceuticals Company Information

13.9.2 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Offered

13.9.3 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Sancilio Pharmaceuticals Main Business Overview

13.9.5 Sancilio Pharmaceuticals Latest Developments

13.10 Zealand Pharma

13.10.1 Zealand Pharma Company Information

13.10.2 Zealand Pharma Short Bowel Syndrome Drugs Product Offered

13.10.3 Zealand Pharma Short Bowel Syndrome Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Zealand Pharma Main Business Overview

13.10.5 Zealand Pharma Latest Developments

14 Research Findings and Conclusion

Table 1. Short Bowel Syndrome Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Short Bowel Syndrome Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Oral Short Bowel Syndrome Drugs

Table 4. Major Players of Tablet Short Bowel Syndrome Drugs

Table 5. Global Short Bowel Syndrome Drugs Sales by Type (2017-2022) & (K Pcs)

Table 6. Global Short Bowel Syndrome Drugs Sales Market Share by Type (2017-2022)

Table 7. Global Short Bowel Syndrome Drugs Revenue by Type (2017-2022) & ($ million)

Table 8. Global Short Bowel Syndrome Drugs Revenue Market Share by Type (2017-2022)

Table 9. Global Short Bowel Syndrome Drugs Sale Price by Type (2017-2022) & (USD/Pcs)

Table 10. Global Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2022) & (K Pcs)

Table 11. Global Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2017-2022)

Table 12. Global Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2022)

Table 13. Global Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2017-2022)

Table 14. Global Short Bowel Syndrome Drugs Sale Price by Sale Channel (2017-2022) & (USD/Pcs)

Table 15. Global Short Bowel Syndrome Drugs Sales by Company (2020-2022) & (K Pcs)

Table 16. Global Short Bowel Syndrome Drugs Sales Market Share by Company (2020-2022)

Table 17. Global Short Bowel Syndrome Drugs Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Short Bowel Syndrome Drugs Revenue Market Share by Company (2020-2022)

Table 19. Global Short Bowel Syndrome Drugs Sale Price by Company (2020-2022) & (USD/Pcs)

Table 20. Key Manufacturers Short Bowel Syndrome Drugs Producing Area Distribution and Sales Area

Table 21. Players Short Bowel Syndrome Drugs Products Offered

Table 22. Short Bowel Syndrome Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Short Bowel Syndrome Drugs Sales by Geographic Region (2017-2022) & (K Pcs)

Table 26. Global Short Bowel Syndrome Drugs Sales Market Share Geographic Region (2017-2022)

Table 27. Global Short Bowel Syndrome Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Short Bowel Syndrome Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Short Bowel Syndrome Drugs Sales by Country/Region (2017-2022) & (K Pcs)

Table 30. Global Short Bowel Syndrome Drugs Sales Market Share by Country/Region (2017-2022)

Table 31. Global Short Bowel Syndrome Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Short Bowel Syndrome Drugs Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Short Bowel Syndrome Drugs Sales by Country (2017-2022) & (K Pcs)

Table 34. Americas Short Bowel Syndrome Drugs Sales Market Share by Country (2017-2022)

Table 35. Americas Short Bowel Syndrome Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Short Bowel Syndrome Drugs Revenue Market Share by Country (2017-2022)

Table 37. Americas Short Bowel Syndrome Drugs Sales by Type (2017-2022) & (K Pcs)

Table 38. Americas Short Bowel Syndrome Drugs Sales Market Share by Type (2017-2022)

Table 39. Americas Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2022) & (K Pcs)

Table 40. Americas Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2017-2022)

Table 41. APAC Short Bowel Syndrome Drugs Sales by Region (2017-2022) & (K Pcs)

Table 42. APAC Short Bowel Syndrome Drugs Sales Market Share by Region (2017-2022)

Table 43. APAC Short Bowel Syndrome Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Short Bowel Syndrome Drugs Revenue Market Share by Region (2017-2022)

Table 45. APAC Short Bowel Syndrome Drugs Sales by Type (2017-2022) & (K Pcs)

Table 46. APAC Short Bowel Syndrome Drugs Sales Market Share by Type (2017-2022)

Table 47. APAC Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2022) & (K Pcs)

Table 48. APAC Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2017-2022)

Table 49. Europe Short Bowel Syndrome Drugs Sales by Country (2017-2022) & (K Pcs)

Table 50. Europe Short Bowel Syndrome Drugs Sales Market Share by Country (2017-2022)

Table 51. Europe Short Bowel Syndrome Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Short Bowel Syndrome Drugs Revenue Market Share by Country (2017-2022)

Table 53. Europe Short Bowel Syndrome Drugs Sales by Type (2017-2022) & (K Pcs)

Table 54. Europe Short Bowel Syndrome Drugs Sales Market Share by Type (2017-2022)

Table 55. Europe Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2022) & (K Pcs)

Table 56. Europe Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2017-2022)

Table 57. Middle East & Africa Short Bowel Syndrome Drugs Sales by Country (2017-2022) & (K Pcs)

Table 58. Middle East & Africa Short Bowel Syndrome Drugs Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Short Bowel Syndrome Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Short Bowel Syndrome Drugs Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Short Bowel Syndrome Drugs Sales by Type (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Short Bowel Syndrome Drugs Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Short Bowel Syndrome Drugs

Table 66. Key Market Challenges & Risks of Short Bowel Syndrome Drugs

Table 67. Key Industry Trends of Short Bowel Syndrome Drugs

Table 68. Short Bowel Syndrome Drugs Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Short Bowel Syndrome Drugs Distributors List

Table 71. Short Bowel Syndrome Drugs Customer List

Table 72. Global Short Bowel Syndrome Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 73. Global Short Bowel Syndrome Drugs Sales Market Forecast by Region

Table 74. Global Short Bowel Syndrome Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Short Bowel Syndrome Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Short Bowel Syndrome Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 77. Americas Short Bowel Syndrome Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Short Bowel Syndrome Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. APAC Short Bowel Syndrome Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Short Bowel Syndrome Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Europe Short Bowel Syndrome Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Short Bowel Syndrome Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Middle East & Africa Short Bowel Syndrome Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Short Bowel Syndrome Drugs Sales Forecast by Type (2023-2028) & (K Pcs)

Table 85. Global Short Bowel Syndrome Drugs Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Short Bowel Syndrome Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Short Bowel Syndrome Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Short Bowel Syndrome Drugs Sales Forecast by Sale Channel (2023-2028) & (K Pcs)

Table 89. Global Short Bowel Syndrome Drugs Sales Market Share Forecast by Sale Channel (2023-2028)

Table 90. Global Short Bowel Syndrome Drugs Revenue Forecast by Sale Channel (2023-2028) & ($ Millions)

Table 91. Global Short Bowel Syndrome Drugs Revenue Market Share Forecast by Sale Channel (2023-2028)

Table 92. Emmaus Medical Basic Information, Short Bowel Syndrome Drugs Manufacturing Base, Sales Area and Its Competitors

Table 93. Emmaus Medical Short Bowel Syndrome Drugs Product Offered

Table 94. Emmaus Medical Short Bowel Syndrome Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 95. Emmaus Medical Main Business

Table 96. Emmaus Medical Latest Developments

Table 97. Merck Basic Information, Short Bowel Syndrome Drugs Manufacturing Base, Sales Area and Its Competitors

Table 98. Merck Short Bowel Syndrome Drugs Product Offered

Table 99. Merck Short Bowel Syndrome Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 100. Merck Main Business

Table 101. Merck Latest Developments

Table 102. Takeda Basic Information, Short Bowel Syndrome Drugs Manufacturing Base, Sales Area and Its Competitors

Table 103. Takeda Short Bowel Syndrome Drugs Product Offered

Table 104. Takeda Short Bowel Syndrome Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 105. Takeda Main Business

Table 106. Takeda Latest Developments

Table 107. Ardelyx Basic Information, Short Bowel Syndrome Drugs Manufacturing Base, Sales Area and Its Competitors

Table 108. Ardelyx Short Bowel Syndrome Drugs Product Offered

Table 109. Ardelyx Short Bowel Syndrome Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 110. Ardelyx Main Business

Table 111. Ardelyx Latest Developments

Table 112. Naia Pharmaceuticals Basic Information, Short Bowel Syndrome Drugs Manufacturing Base, Sales Area and Its Competitors

Table 113. Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Offered

Table 114. Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 115. Naia Pharmaceuticals Main Business

Table 116. Naia Pharmaceuticals Latest Developments

Table 117. Nutrinia Basic Information, Short Bowel Syndrome Drugs Manufacturing Base, Sales Area and Its Competitors

Table 118. Nutrinia Short Bowel Syndrome Drugs Product Offered

Table 119. Nutrinia Short Bowel Syndrome Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 120. Nutrinia Main Business

Table 121. Nutrinia Latest Developments

Table 122. OxThera Basic Information, Short Bowel Syndrome Drugs Manufacturing Base, Sales Area and Its Competitors

Table 123. OxThera Short Bowel Syndrome Drugs Product Offered

Table 124. OxThera Short Bowel Syndrome Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 125. OxThera Main Business

Table 126. OxThera Latest Developments

Table 127. GLyPharma Therapeutic Basic Information, Short Bowel Syndrome Drugs Manufacturing Base, Sales Area and Its Competitors

Table 128. GLyPharma Therapeutic Short Bowel Syndrome Drugs Product Offered

Table 129. GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 130. GLyPharma Therapeutic Main Business

Table 131. GLyPharma Therapeutic Latest Developments

Table 132. Sancilio Pharmaceuticals Basic Information, Short Bowel Syndrome Drugs Manufacturing Base, Sales Area and Its Competitors

Table 133. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Offered

Table 134. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 135. Sancilio Pharmaceuticals Main Business

Table 136. Sancilio Pharmaceuticals Latest Developments

Table 137. Zealand Pharma Basic Information, Short Bowel Syndrome Drugs Manufacturing Base, Sales Area and Its Competitors

Table 138. Zealand Pharma Short Bowel Syndrome Drugs Product Offered

Table 139. Zealand Pharma Short Bowel Syndrome Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 140. Zealand Pharma Main Business

Table 141. Zealand Pharma Latest Developments

List of Figures

Figure 1. Picture of Short Bowel Syndrome Drugs

Figure 2. Short Bowel Syndrome Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Short Bowel Syndrome Drugs Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Short Bowel Syndrome Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Short Bowel Syndrome Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Oral Short Bowel Syndrome Drugs

Figure 10. Product Picture of Tablet Short Bowel Syndrome Drugs

Figure 11. Global Short Bowel Syndrome Drugs Sales Market Share by Type in 2021

Figure 12. Global Short Bowel Syndrome Drugs Revenue Market Share by Type (2017-2022)

Figure 13. Short Bowel Syndrome Drugs Consumed in Hospital Pharmacies

Figure 14. Global Short Bowel Syndrome Drugs Market: Hospital Pharmacies (2017-2022) & (K Pcs)

Figure 15. Short Bowel Syndrome Drugs Consumed in Retail Pharmacies

Figure 16. Global Short Bowel Syndrome Drugs Market: Retail Pharmacies (2017-2022) & (K Pcs)

Figure 17. Short Bowel Syndrome Drugs Consumed in Online Pharmacies

Figure 18. Global Short Bowel Syndrome Drugs Market: Online Pharmacies (2017-2022) & (K Pcs)

Figure 19. Global Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2017-2022)

Figure 20. Global Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel in 2021

Figure 21. Short Bowel Syndrome Drugs Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Short Bowel Syndrome Drugs Revenue Market Share by Company in 2021

Figure 23. Global Short Bowel Syndrome Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Short Bowel Syndrome Drugs Revenue Market Share by Geographic Region in 2021

Figure 25. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2017-2022)

Figure 26. Global Short Bowel Syndrome Drugs Revenue Market Share by Country/Region in 2021

Figure 27. Americas Short Bowel Syndrome Drugs Sales 2017-2022 (K Pcs)

Figure 28. Americas Short Bowel Syndrome Drugs Revenue 2017-2022 ($ Millions)

Figure 29. APAC Short Bowel Syndrome Drugs Sales 2017-2022 (K Pcs)

Figure 30. APAC Short Bowel Syndrome Drugs Revenue 2017-2022 ($ Millions)

Figure 31. Europe Short Bowel Syndrome Drugs Sales 2017-2022 (K Pcs)

Figure 32. Europe Short Bowel Syndrome Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Short Bowel Syndrome Drugs Sales 2017-2022 (K Pcs)

Figure 34. Middle East & Africa Short Bowel Syndrome Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Americas Short Bowel Syndrome Drugs Sales Market Share by Country in 2021

Figure 36. Americas Short Bowel Syndrome Drugs Revenue Market Share by Country in 2021

Figure 37. United States Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Short Bowel Syndrome Drugs Sales Market Share by Region in 2021

Figure 42. APAC Short Bowel Syndrome Drugs Revenue Market Share by Regions in 2021

Figure 43. China Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Short Bowel Syndrome Drugs Sales Market Share by Country in 2021

Figure 50. Europe Short Bowel Syndrome Drugs Revenue Market Share by Country in 2021

Figure 51. Germany Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Short Bowel Syndrome Drugs Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Short Bowel Syndrome Drugs Revenue Market Share by Country in 2021

Figure 58. Egypt Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Short Bowel Syndrome Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Short Bowel Syndrome Drugs in 2021

Figure 64. Manufacturing Process Analysis of Short Bowel Syndrome Drugs

Figure 65. Industry Chain Structure of Short Bowel Syndrome Drugs

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles